Point of Care Diagnostics: Lab on a Chip

NeuroDynamic Strategies, LLC (NDS) has been involved in both research and commercialization of technologies within the dental market space for the last seven years. Over the last three years we have been actively pursuing the commercialization of Lab on a Chip (LOC) technology. As advances continue to be made, the opportunity to use Point of Care Diagnostics in broad and multiple applications is coming closer and closer to reality with the potential for positive human health interventions no longer a dream but an attainable goal.

LOC brings rapid, accurate, diagnostic capacity to individuals through their dentist, doctor, clinic or local pharmacy. If given knowledge, these patients can adjust their lifestyle and/or begin early interventions for conditions that if treated in the early stages will be, at a minimum, well-managed but if treatment is delayed, debilitating or deadly.

The strategic power that NDS brings to this commercialization activity is anchored by our understanding of the science involved and the dental and medical diagnostic market as well as our capacity to bring multiple and multi-faceted business relationships together among companies and researchers who can convert these technologies into products.

The trend in personal and proactive wellness is evident today, and the desire by doctors and dentists to have affordable diagnostic tools continues to escalate. The fastest growing market segment, the baby boomers, are demanding this type of personal health monitoring and are predicted to influence a more rapid conversion of LOC Diagnostics from the newest gadget on the shelf to a normative diagnostic tool commonly found wherever patients are cared for and treated.

With this and other trends* in the diagnostic field, we believe the future of health care is Point of Care, specifically LOC Diagnostics™.

Opportunity
NeuroDynamic Strategies, LLC is currently seeking partners in this commercialization opportunity through investment in its holding company Sarcio Group, LLC.

About
NeuroDynamic Strategies, LLC was founded in the spring of 2002 to bring to market meaningful and effective tools, protocols, technologies, and strategies to remediate the effects of stress and pain at their most senior levels of influence, the brain and central nervous system. These tools for change will help to adjust the neurological terrain of the brain and central nervous system, enriching its ability and capacity to respond positively and with resiliency to stress.

Comfort Centered Dentistry (formerly called Positive Experience Dentistry) was developed and tested within NDS. As part of a restructuring, this protocol was transferred to Sarcio Group, LLC, a holding company, and subsequently to Solace Solutions, LLC, our sister company dedicated to advancing technologies into the dental market.

NDS has focused on the tools and technologies associated with Point of Care and the Lab on a Chip Technology for the last three years. It is an exciting and dynamic time to be associated with this technology, participating in making this new paradigm for diagnostics the norm.

Company Vision
NeuroDynamic Strategies, LLC seeks out Point of Care technology applications and advances these into the market with highly skilled business partners to bring to individual patients the earliest, most accurate diagnostic tools available assuring a significantly greater chance of timely treatment and sustained health.

Background
Innovations in Diagnostics: Next Generation Molecular and Point-of-Care Diagnostics Driving Personalized Healthcare
http://www.researchandmarkets.com/

The global diagnostics market is undergoing radical change; novel technologies driven by miniaturization and advances in genomics will enhance the role of diagnostics in the healthcare market, allowing more tests to be performed at the point-of-care and facilitating the shift towards personalized medicine. “Innovation in Diagnostics” examines the advances in the rapidly growing field of molecular technologies that are enabling personalized healthcare to move into mainstream medicine.

New opportunities in infectious disease testing, molecular oncology and pharmacogenomics are explored in detail, enabling you to understand the forces that are driving in vitro diagnostics (IVDs) into center stage of the healthcare arena. We can help you understand the changing relationship between IVD companies and the pharmaceutical industry, assess the convergence of IVDs and medical imaging, and develop an understanding of new technologies that will influence diagnostic product development and drug development programs.

Contact Information:
Marcia Marye Denton, M.A., M.Ed. President/COO
G. Blake Holloway, M. Phil, V. President/CSO
Sarcio Group, LLC;
PO. Box 295098, Kerrville, TX 78029
830 792 3123 v
830 792 3122 f.

Sarcio Group, LLC includes:

Solace Solutions, LLC
www.solacesolutions.com
info@solacesolutions.com

NeuroDynamic Strategies, LLC
www.neurodynamicstrategies.com
info@neurodynamicstrategies.com

This information contains forward looking statements that are not guaranteed

For More Information:

Solace Solutions
CCD
Comfort Centered Dentistry
Positive Experience Dentistry
Anxiety